Table 9. LDGs and NDGs in HIV+ patients in CD4high HIV+ patients.
| LDGs | NDGs | p value | |
| (median ± SEM) | (median ± SEM) | ||
| CD11b | 4413±694 | 2684±767 | 0.5994 |
| CD13 | 2137±564 | 3915±345 | 0.1007 |
| CD15 | 10012±1277 | 2270±693 | 0.0003 |
| CD16 | 1528±1483 | 10259±934 | 0.0216 |
| CD33 | 3575±285 | 2114±196 | 0.0016 |
| CD63 | 1474±178 | 751±57 | 0.0001 |
| CD66b | 8899±1775 | 7697±604 | 0.1679 |
| arginase | 1700±141 | 2294±150 | 0.0126 |
Ldgs And Ndgs Were Isolated From The Blood Of Hiv+ Patients With Cd4+ T Cell Counts >350 Cells/µL (N = 11) As Described In Materials And Methods. Expression Levels Of Phenotypic Markers Were Determined By Flow Cytometry.